Bausch Health Companies (BHC) Inventory (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Inventory data on file, last reported at $1.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 0.74% year-over-year to $1.6 billion; the trailing twelve-month figure through Mar 2026 stood at $1.6 billion (down 0.74% YoY), and the FY2025 full-year result was $1.6 billion, up 2.13% from the prior year.
• Inventory eased to $1.6 billion in Q1 2026, from $1.6 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.7 billion in Q3 2024 to a low of $1.0 billion in Q1 2022.
• A 5-year average of $1.4 billion and a median of $1.6 billion in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory surged 41.65% in 2023 and declined 3.44% in 2025, its largest moves.
• Tracing BHC's Inventory over 5 years: stood at $1.1 billion in 2022, then surged by 41.65% to $1.5 billion in 2023, then advanced by 3.3% to $1.6 billion in 2024, then gained by 2.13% to $1.6 billion in 2025, then dropped by 1.72% to $1.6 billion in 2026.
• Business Quant data shows BHC's Inventory at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.